conduct
challengerechalleng
trial
alpaca
infect
middl
east
respiratori
syndrom
coronaviru
alpaca
shed
viru
challeng
refractori
shed
rechalleng
day
trial
indic
alpaca
may
suitabl
model
infect
shed
dynam
viru
merscov
first
report
septemb
sinc
confirm
case
report
world
health
organ
http
wwwwhointcsr
role
domest
anim
intermedi
host
human
initi
suggest
case
histori
infect
patient
visit
farm
tend
sick
anim
shortli
onset
infect
suggest
given
credenc
studi
camel
serum
sampl
show
high
level
neutral
antibodi
dispar
camel
popul
find
subsequ
confirm
viru
detect
sequenc
infect
trial
camel
limit
mainli
difficulti
hous
handl
anim
highcontain
facil
necessari
viru
biosafeti
level
classif
howev
alpaca
close
rel
within
camelida
famili
may
provid
temperament
suitabl
valuabl
anim
model
merscov
infect
particularli
develop
test
vaccin
candid
camel
sought
assess
whether
alpaca
could
infect
mean
natur
oronas
rout
determin
whether
viral
shed
occur
reinfect
evalu
develop
serolog
marker
protect
obtain
adult
femal
alpaca
vicugna
paco
commerci
supplier
victoria
australia
hous
biosafeti
level
contain
facil
csiro
australian
anim
health
laboratori
experi
alpaca
allow
acclimat
day
time
intrauterin
temperatur
data
logger
implant
accord
previous
publish
procedur
found
previou
merscov
challeng
trial
report
alpaca
chose
preliminari
dose
rechalleng
time
basi
experi
viru
infect
trial
emerg
infecti
diseas
use
camel
isol
merscov
dromedari
genbank
access
no
infect
isol
prepar
vero
cell
describ
alpaca
expos
oronas
tissu
cultur
infect
dose
merscov
ml
phosphatebuff
salin
anim
monitor
day
reexpos
replic
challeng
merscov
observ
day
clinic
sampl
blood
edta
obtain
serum
swab
deep
superfici
nasal
oral
rectal
urogenit
collect
immedi
inocul
thereaft
day
alpaca
elect
euthan
day
other
day
anim
remain
clinic
healthi
except
reduc
condit
score
occur
day
anim
alpaca
sign
upper
lower
respiratori
tract
diseas
appear
anim
increas
temperatur
note
alpaca
day
fever
rectal
temperatur
record
gross
abnorm
postmortem
examin
found
alpaca
compris
extens
adhes
caudal
sac
compart
stomach
umbilicu
clinic
find
anim
attribut
lesion
rna
extract
realtim
pcr
perform
follow
specimenhandl
procedur
establish
hendra
viru
use
identifi
shed
pattern
challeng
initi
challeng
tabl
viru
isol
undertaken
vero
cell
use
publish
protocol
success
anim
type
sampl
viru
recoveri
success
oral
superfici
nasal
swab
sampl
day
deep
nasal
swab
sampl
posit
day
urogenit
rectal
swab
sampl
neg
realtim
pcr
viru
isol
rechalleng
viral
rna
detect
confid
sampl
figur
serum
sampl
assess
immunolog
respons
use
viru
neutral
test
vnt
luminex
bead
assay
nucleocapsid
protein
use
inhous
assay
model
previous
develop
assess
serolog
statu
feral
camel
central
australia
anim
seroneg
luminex
vnt
challeng
antibodi
first
detect
luminex
day
day
anim
tabl
neutral
antibodi
titer
alpaca
day
neutral
antibodi
titer
detect
alpaca
day
alpaca
time
studi
control
use
merscov
posit
neg
serum
sampl
egypt
australia
onlin
technic
appendix
tabl
http
studi
confirm
alpaca
suscept
merscov
infect
find
consist
previou
report
show
alpaca
kidney
cell
line
possess
dipeptidyl
receptor
could
infect
vitro
challengerechalleng
trial
plan
first
stage
assess
alpaca
potenti
surrog
camel
merscov
vaccin
test
consequ
trial
design
direct
comparison
previou
merscov
challeng
trial
report
camel
trial
use
lower
challeng
dose
differ
timefram
observ
nevertheless
preliminari
compar
observ
may
use
previou
studi
anim
inocul
oronas
rout
live
viru
detect
day
postinfect
similarli
neutral
antibodi
detect
begin
day
postinfect
howev
find
trial
camel
differ
consider
find
trial
trial
camel
detect
live
viru
nasal
wash
day
nasal
discharg
transient
temperatur
rise
viral
rna
detect
realtim
pcr
extend
period
furthermor
vnt
titer
camel
much
higher
alpaca
studi
differ
possibl
repres
underli
dissimilar
immun
respons
merscov
speci
may
also
result
higher
infect
dose
tissu
cultur
infect
dose
use
camel
studi
studi
show
alpaca
secret
live
viru
oronas
infect
immun
respons
initi
infect
prevent
excret
follow
reinfect
underli
assumpt
trial
initi
infect
equat
natur
vaccin
lack
viral
excret
thu
follow
induc
immun
memori
respons
howev
result
indic
immunolog
respons
complex
although
strong
serolog
respons
develop
alpaca
alpaca
refractori
reinfect
studi
sever
limit
first
preliminari
studi
anim
function
proof
concept
definit
studi
use
alpaca
model
studi
infect
dynam
merscov
camelid
second
observ
period
day
rechalleng
inform
provid
complet
inform
durat
protect
immun
futur
studi
larger
sampl
longer
period
studi
postinocul
third
studi
seek
understand
pathogenesi
infect
conduct
histopatholog
immunohistochemistri
understand
site
initi
viral
replic
role
mucos
immun
mount
effect
immun
respons
upon
infect
notwithstand
limit
believ
alpaca
might
use
model
could
greatli
facilit
develop
test
vaccin
candid
recommend
research
trial
substanti
potenti
experiment
infect
alpaca
merscov
